12:00 AM
 | 
May 27, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Cardiovascular disease
Coronary artery disease (CAD) Apolipoprotein A-V (APOA5) ...

Read the full 174 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >